De Burlo Group’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-6,700
Closed -$475K 86
2019
Q4
$475K Hold
6,700
0.1% 69
2019
Q3
$501K Sell
6,700
-400
-6% -$33.9K 0.11% 64
2019
Q2
$573K Hold
7,100
0.11% 70
2019
Q1
$475K Sell
7,100
-2,000
-22% -$151K 0.1% 81
2018
Q4
$677K Sell
9,100
-1,400
-13% -$116K 0.15% 71
2018
Q3
$966K Hold
10,500
0.18% 86
2018
Q2
$1.03M Hold
10,500
0.22% 76
2018
Q1
$1.17M Sell
10,500
-100
-0.9% -$11.2K 0.25% 68
2017
Q4
$1.09M Hold
10,600
0.22% 72
2017
Q3
$998K Sell
10,600
-200
-2% -$15.8K 0.22% 73
2017
Q2
$841K Sell
10,800
-26,700
-71% -$2.01M 0.19% 75
2017
Q1
$3M Sell
37,500
-32,700
-47% -$2.6M 0.65% 42
2016
Q4
$5.53M Buy
70,200
+12,400
+21% +$964K 1.35% 30
2016
Q3
$4.51M Sell
57,800
-21,000
-27% -$1.52M 1.25% 32
2016
Q2
$5.42M Sell
78,800
-67,500
-46% -$4.66M 1.31% 34
2016
Q1
$10.4M Buy
146,300
+35,200
+32% +$2.21M 3.02% 6
2015
Q4
$6.9M Sell
111,100
-13,000
-10% -$793K 1.62% 25
2015
Q3
$7.04M Hold
124,100
1.65% 25
2015
Q2
$6.66M Buy
124,100
+14,900
+14% +$725K 1.39% 34
2015
Q1
$5.19M Buy
109,200
+19,800
+22% +$876K 1.03% 42
2014
Q4
$3.87M Buy
+89,400
New +$3.65M 0.78% 53

Other funds holding CMD

De Burlo Group's CMD Position: Q1 2020 in Review

De Burlo Group sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 6,700 shares — an estimated $475K sold.

De Burlo Group first reported a position in CMD in Q4 2014 and held it in 21 quarters. The position peaked at $10.4M in Q1 2016. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

  • De Burlo Group reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
  • De Burlo Group sold 6,700 Cantel Medical Corporation shares in Q1 2020, an estimated $475K.
  • De Burlo Group first reported a position in Cantel Medical Corporation in Q4 2014 and held it in 21 quarters.
  • De Burlo Group's Cantel Medical Corporation position peaked at $10.4M in Q1 2016.
  • 213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on De Burlo Group's 13F filing for Q1 2020, filed 7 May 2020.